Blood Filtration and Purification Market Report 2025

The blood filtration and purification market size has grown rapidly in recent years. It will grow from $3.96 billion in 2024 to $4.38 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to the rising incidence of chronic kidney diseases, increasing prevalence of blood-related disorders, growing awareness of the benefits of blood purification, expansion of healthcare infrastructure, and higher adoption of dialysis treatments.

The blood filtration and purification market size is expected to see rapid growth in the next few years. It will grow to $6.47 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to an expanding geriatric population, rising incidence of sepsis and organ failure, increasing demand for advanced extracorporeal therapies, broader availability of medical devices, and a growing focus on preventive healthcare. Major trends in the forecast period include innovations in molecular diagnostics, adoption of advanced membrane technologies, integration of artificial intelligence (AI), use of hybrid filtration techniques, and development of smart filters.

The rising prevalence of blood-related disorders is anticipated to drive the growth of the blood filtration and purification market in the coming years. Blood-related disorders are medical conditions that affect the blood’s cells, components, or functions. The occurrence of these disorders is increasing due to the aging global population, as older individuals are more prone to conditions impacting blood health, resulting in higher incidence rates and greater demand for diagnosis and treatment. Blood filtration and purification aid in managing blood-related disorders by efficiently removing toxins and harmful elements from the blood, helping to restore healthy blood function and alleviate disease symptoms. For example, in November 2024, the American Society of Hematology, a US-based non-profit organization, reported that new leukemia cases in the US are projected to increase from 461,423 in 2021 to 519,540 by 2050. Consequently, the growing prevalence of blood-related disorders is fueling the expansion of the blood filtration and purification market.

Leading companies in the blood filtration and purification market are focusing on developing advanced solutions, such as improved touchscreen interfaces, to provide user-friendly systems that simplify dialysis procedures and enhance the patient experience in home-based therapies. The enhanced touchscreen interface offers an upgraded, intuitive display with improved graphics and navigation, making it easier to operate home hemodialysis systems. For instance, in August 2023, Fresenius Medical Care, a Germany-based healthcare company, received FDA clearance for VersiHD with GuideMe Software. This state-of-the-art home hemodialysis system combines a reliable dialysis machine with a self-guided, intuitive interface designed to make treatment more accessible for patients and caregivers. It provides clear, step-by-step visual instructions to enhance usability, boost patient confidence, and reduce training time, enabling more individuals to manage dialysis at home. Leveraging NxStage’s extensive experience in home hemodialysis, this system delivers effective blood filtration and purification for patients with chronic kidney disease, allowing them to safely and comfortably perform dialysis independently.

In December 2024, GVS S.p.A., an Italy-based filtration solutions company, acquired the whole blood business of Haemonetics Corporation for an undisclosed sum. Through this acquisition, GVS S.p.A. seeks to expand its product portfolio by incorporating Haemonetics’ specialized blood collection, processing, filtration, and transfusion technologies. Haemonetics Corporation, a US-based company, offers a range of blood management solutions, including blood filtration and purification.

Major players in the blood filtration and purification market are Thermo Fisher Scientific Inc., Asahi Kasei Corporation, Fresenius SE & Co. KGaA, Toray Industries Inc., Baxter International Inc., DaVita Inc., Kaneka Corporation, Nipro Corporation, Nikkiso Co. Ltd., Jafron Biomedical Co. Ltd., Satellite Healthcare Inc., B. Braun Melsungen AG, Biotage AB, CytoSorbents Europe GmbH, Medica S.p.A., SWS Medical Group, Spectral Medical Inc., ExThera Medical Corporation, Infomed SA, Baihe Medical Co. Ltd., and Guangdong Biolight Meditech Co. Ltd.

North America was the largest region in the blood filtration and purification market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in blood filtration and purification market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the blood filtration and purification market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

Blood filtration and purification is a medical procedure designed to remove impurities, toxins, excess fluids, or harmful substances from the blood, helping restore its normal composition and improve patient health. This process employs specialized devices and techniques to clean the blood outside the body before returning it, supporting organ function, controlling infections, and maintaining physiological balance in critically ill patients.

The primary products in blood filtration and purification include filtration kits and reagents, membranes, filters and consumables, sample preparation systems, and specialty assays and columns. Filtration kits and reagents consist of specialized components and chemicals used in medical and laboratory procedures to filter and prepare blood or biological samples. These products are applied in infectious disease diagnostics, toxicology and immunodiagnostics, cancer diagnostics, genetic or molecular diagnostics, and more. Key end users include clinical diagnostic laboratories, hospitals, research and academic institutions, and other healthcare facilities.

The blood filtration and purification market research report is one of a series of new reports that provides blood filtration and purification market statistics, including blood filtration and purification industry global market size, regional shares, competitors with a blood filtration and purification market share, detailed blood filtration and purification market segments, market trends and opportunities, and any further data you may need to thrive in the blood filtration and purification industry. This blood filtration and purification market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood filtration and purification market consists of revenues earned by entities by provide services such as therapeutic blood purification procedures, separation services, and support for biopharmaceutical manufacturing. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood filtration and purification market also includes sales of blood filters, diagnostic tools, and replacement therapy accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.